Cargando…
Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunologic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741720/ https://www.ncbi.nlm.nih.gov/pubmed/34837504 http://dx.doi.org/10.1007/s00125-021-05612-2 |
_version_ | 1784629554229280768 |
---|---|
author | Miettinen, Maija E. Honkanen, Jarno Niinistö, Sari Vaarala, Outi Virtanen, Suvi M. Knip, Mikael |
author_facet | Miettinen, Maija E. Honkanen, Jarno Niinistö, Sari Vaarala, Outi Virtanen, Suvi M. Knip, Mikael |
author_sort | Miettinen, Maija E. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunological markers (cytokines, chemokines and growth factors) in serum samples from Finnish (56 individuals, 147 samples), Estonian (56 individuals 148 samples) and Russian Karelian children (62 individuals, 149 samples) at 3, 6, 12, 18, 24 and 36 months of age. We also analysed gut inflammation markers (calprotectin and human β defensin-2) at 3 (n = 96) and 6 months (n = 153) of age. Comparisons of immunological marker medians were performed between children who were breastfed for 6 months or longer vs children who were breastfed for less than 6 months. RESULTS: Breastfeeding for 6 months or longer vs less than 6 months was associated with lower median of serum immunological markers at 6 months (granulocyte-macrophage colony-stimulating factor [GMCSF], macrophage inflammatory protein [MIP-3α]), 12 months (IFN-α2, vascular endothelial growth factor, GMCSF, IFN-γ, IL-21), 18 months (FGF-2, IFN-α2) and 24 months of age (CCL11 [eotaxin], monocyte chemoattractant protein-1, TGFα, soluble CD40 ligand, IL-13, IL-21, IL-5, MIP-1α) (all p < 0.01) but not at 36 months of age. Breastfeeding was not associated with gut inflammation markers at 3 and 6 months of age. CONCLUSIONS/INTERPRETATION: Children who were breastfed for 6 months or longer had lower medians for 14 immunological markers at one or more age points during the first 2 years of life compared with children who were breastfed for less than 6 months. The clinical meaning of the findings is not clear. However, the present study contributes to the understanding of immunological differences in children that have been breastfed longer, and thus provides a mechanistic suggestion for the previously observed associations between breastfeeding and risk of type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8741720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-87417202022-01-20 Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study Miettinen, Maija E. Honkanen, Jarno Niinistö, Sari Vaarala, Outi Virtanen, Suvi M. Knip, Mikael Diabetologia Short Communication AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunological markers (cytokines, chemokines and growth factors) in serum samples from Finnish (56 individuals, 147 samples), Estonian (56 individuals 148 samples) and Russian Karelian children (62 individuals, 149 samples) at 3, 6, 12, 18, 24 and 36 months of age. We also analysed gut inflammation markers (calprotectin and human β defensin-2) at 3 (n = 96) and 6 months (n = 153) of age. Comparisons of immunological marker medians were performed between children who were breastfed for 6 months or longer vs children who were breastfed for less than 6 months. RESULTS: Breastfeeding for 6 months or longer vs less than 6 months was associated with lower median of serum immunological markers at 6 months (granulocyte-macrophage colony-stimulating factor [GMCSF], macrophage inflammatory protein [MIP-3α]), 12 months (IFN-α2, vascular endothelial growth factor, GMCSF, IFN-γ, IL-21), 18 months (FGF-2, IFN-α2) and 24 months of age (CCL11 [eotaxin], monocyte chemoattractant protein-1, TGFα, soluble CD40 ligand, IL-13, IL-21, IL-5, MIP-1α) (all p < 0.01) but not at 36 months of age. Breastfeeding was not associated with gut inflammation markers at 3 and 6 months of age. CONCLUSIONS/INTERPRETATION: Children who were breastfed for 6 months or longer had lower medians for 14 immunological markers at one or more age points during the first 2 years of life compared with children who were breastfed for less than 6 months. The clinical meaning of the findings is not clear. However, the present study contributes to the understanding of immunological differences in children that have been breastfed longer, and thus provides a mechanistic suggestion for the previously observed associations between breastfeeding and risk of type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2021-11-27 2022 /pmc/articles/PMC8741720/ /pubmed/34837504 http://dx.doi.org/10.1007/s00125-021-05612-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Short Communication Miettinen, Maija E. Honkanen, Jarno Niinistö, Sari Vaarala, Outi Virtanen, Suvi M. Knip, Mikael Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title | Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title_full | Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title_fullStr | Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title_full_unstemmed | Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title_short | Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study |
title_sort | breastfeeding and circulating immunological markers during the first 3 years of life: the diabimmune study |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741720/ https://www.ncbi.nlm.nih.gov/pubmed/34837504 http://dx.doi.org/10.1007/s00125-021-05612-2 |
work_keys_str_mv | AT miettinenmaijae breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT honkanenjarno breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT niinistosari breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT vaaralaouti breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT virtanensuvim breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT knipmikael breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy AT breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy |